|
ANKMY2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.641900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.239700E-02 |
| Normal-vs-Stage2 |
6.925200E-01 |
| Normal-vs-Stage3 |
3.743200E-01 |
| Normal-vs-Stage4 |
2.854000E-01 |
| Stage1-vs-Stage2 |
2.206800E-01 |
| Stage1-vs-Stage3 |
4.801800E-02 |
| Stage1-vs-Stage4 |
3.270400E-02 |
| Stage2-vs-Stage3 |
3.171200E-01 |
| Stage2-vs-Stage4 |
2.877200E-01 |
| Stage3-vs-Stage4 |
9.009000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.972000E-02 |
| Normal-vs-AfricanAmerican |
8.625700E-02 |
| Normal-vs-Asian |
8.688600E-01 |
| Caucasian-vs-AfricanAmerican |
7.263000E-01 |
| Caucasian-vs-Asian |
7.378200E-01 |
| AfricanAmerican-vs-Asian |
6.277000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.762000E-02 |
| Normal-vs-Female |
3.903800E-02 |
| Male-vs-Female |
3.369200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.918400E-01 |
| Normal-vs-Extreme_Weight |
1.896360E-01 |
| Normal-vs-Obese |
1.372980E-01 |
| Normal-vs-Extreme_Obese |
6.978800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.893600E-01 |
| Normal_Weight-vs-Obese |
5.257000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.460400E-01 |
| Extreme_Weight-vs-Obese |
9.928800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.117000E-01 |
| Obese-vs-Extreme_Obese |
7.496000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.846800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.028440E-02 |
| Normal-vs-Age(61-80Yrs) |
3.460600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.249800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.163200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.134200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.550600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.791700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.763600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.488600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.430400E-04 |
| Normal-VS-Type2 PRCC |
4.498200E-01 |
| Normal-VS-KIRP CIMP |
3.286200E-02 |
| Normal-VS-Unclassified PRCC |
8.904300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.155200E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.579700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.366800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.460800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.974000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.294100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.694400E-01 |
| Normal-vs-N1 |
3.054800E-01 |
| Normal-vs-N2 |
1.372040E-01 |
| N0-vs-N1 |
5.674000E-01 |
| N0-vs-N2 |
2.932400E-02 |
| N1-vs-N2 |
2.250800E-01 |
|
|
